Bristol-Myers Squibb (BMY) Files Mixed Shelf Registration Statement

Go back to Bristol-Myers Squibb (BMY) Files Mixed Shelf Registration Statement

Bristol-Myers Squibb (BMY) Raises Quarterly Dividend 10.2% to $0.54; 3.8% Yield

December 13, 2021 7:03 AM EST

Bristol-Myers Squibb (NYSE: BMY) declared a quarterly dividend of $0.54 per share, or $2.16 annualized. This is a 10.2% increase from the prior dividend of $0.49.

The dividend will be payable on February 1, 2022, to stockholders of record on January 7, 2022, with an ex-dividend date of January 6,... More

Bristol-Myers Squibb (BMY) Announces Dividend Increase, Additional $15 Billion Share Repurchase

December 13, 2021 6:59 AM EST

Bristol Myers Squibb (NYSE: BMY) today announced that on December 10, 2021, its Board of Directors approved an increase in the quarterly dividend and authorized an additional multi-year share repurchase program.

The companys financial position is strong, and we remain committed to a consistent, balanced capital allocation strategy, said... More

Bristol-Myers Squibb's (BMY) Breyanzi Significantly Improves Outcomes, Showing Superiority Over 20-Year Standard of Care in Second-Line Relapsed or Refractory Large B-cell Lymphoma Based on TRANSFORM

December 13, 2021 5:25 AM EST

Bristol Myers Squibb (NYSE: BMY) today... More